{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:21:06Z","timestamp":1760833266779,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.nmd.2023.10.009","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T10:59:18Z","timestamp":1697281158000},"page":"40-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The use of guidelines to assess the risk of malignant hyperthermia in individuals with an RYR1 variant"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5837-7295","authenticated-orcid":false,"given":"N.C.","family":"Voermans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Girard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"Kamsteeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11\u201312","key":"10.1016\/j.nmd.2023.10.009_bib0001","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.nmd.2022.10.003","article-title":"Risk of malignant hyperthermia in patients carrying a variant in the skeletal muscle ryanodine receptor 1 gene","volume":"32","author":"Janssens","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2023.10.009_bib0002","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/ALN.0000000000004199","article-title":"Referral indications for malignant hyperthermia susceptibility diagnostics in patients without adverse anesthetic events in the era of next-generation sequencing","volume":"136","author":"van den Bersselaar","year":"2022","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.nmd.2023.10.009_bib0003","doi-asserted-by":"crossref","first-page":"fcac292","DOI":"10.1093\/braincomms\/fcac292","article-title":"Neuromuscular symptoms in patients with RYR1-related malignant hyperthermia and rhabdomyolysis","volume":"4","author":"van den Bersselaar","year":"2022","journal-title":"Brain Commun"},{"issue":"4","key":"10.1016\/j.nmd.2023.10.009_bib0004","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth."},{"issue":"8","key":"10.1016\/j.nmd.2023.10.009_bib0005","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1399-6576.2005.00755.x","article-title":"McArdle's disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia","volume":"49","author":"Bollig","year":"2005","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"10.1016\/j.nmd.2023.10.009_bib0006","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/bja\/68.1.72","article-title":"In vitro contracture tests in patients with various neuromuscular diseases","volume":"68","author":"Heytens","year":"1992","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2023.10.009_bib0007","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1093\/hmg\/ddac145","article-title":"Updated variant curation expert panel criteria and pathogenicity classifications for 251 variants for RYR1-related malignant hyperthermia susceptibility","volume":"31","author":"Johnston","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.nmd.2023.10.009_bib0008","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bja.2018.06.028","article-title":"Genetic epidemiology of malignant hyperthermia in the UK","volume":"121","author":"Miller","year":"2018","journal-title":"Br J Anaesth"},{"issue":"12","key":"10.1016\/j.nmd.2023.10.009_bib0009","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1111\/ene.15526","article-title":"European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders","volume":"29","author":"van den Bersselaar","year":"2022","journal-title":"Eur J Neurol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662300754X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662300754X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:14:11Z","timestamp":1760775251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089662300754X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":9,"alternative-id":["S096089662300754X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.10.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of guidelines to assess the risk of malignant hyperthermia in individuals with an RYR1 variant","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}